Clinical application of opioid equianalgesic data

Clinical Journal of Pain

Volumn 19, Issue 5, 2003, Pages 286-297

  Gammaitoni, Arnold R ^a   Fine, Perry ^b   Alvarez, Nancy ^a   McPherson, Mary Lynn ^c   Bergmark, Suzette ^d  

^a ENDO PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Dosing; Equianalgesia; Equianalgesic ratios; Opioid; Opioid dose conversion

Indexed keywords

CAPTOPRIL; CODEINE; DEXAMETHASONE; FENTANYL; GABAPENTIN; GLIBENCLAMIDE; HYDROCODONE; HYDROMORPHONE; LAXATIVE; LEVORPHANOL; LONG ACTING DRUG; LORATADINE; METHADONE; MORPHINE; MORPHINE SULFATE; NAPROXEN; NORPETHIDINE; OMEPRAZOLE; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL; PERCOCET; PETHIDINE; TIZANIDINE;

ADULT; AGITATION; ALGORITHM; ANALGESIA; ARTICLE; BIOEQUIVALENCE; BOOK; CASE REPORT; DOSE CALCULATION; DOSE RESPONSE; DRUG FORMULATION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MALE; MEDICAL LITERATURE; NURSE; PAIN; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; SEDATION; SEIZURE; SIDE EFFECT; SLOW RELEASE FORMULATION; STANDARDIZATION; TABLET FORMULATION; TRAINING;

ALGORITHMS; ANALGESICS, OPIOID; CASE MANAGEMENT; CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PRACTICE GUIDELINES;

EID: 0042329272     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200309000-00002     Document Type: Article

References (28)

1. Levy MH. Pharmacologic treatment of cancer pain. N Eng J Med. 1996;335:1124-1132.
2. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50: 1837-1841.
3. Galer BS, Gammaitoni AR, Alvarez NA. Pain. In: Dale DC, Federman DG, eds. Scientific American Medicine; 2001. Chapter 11. XIV.
4. Houde RW, Wallenstein SL, Roger A. Clinical pharmacology of analgesics: a method of assaying analgesic effect. Clin Pharmacol Ther. 1960;1:163-174.
5. Beaver WT, Wallenstein SL, Rogers A, et al. Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine. J Clin Pharm Ther. 1978;207:101-108.
6. Beaver WT, Wallenstein SL, Rogers A. et al. Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone. J Clin Pharm Ther. 1978;207:92-100.
7. Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther. 1990;47:639-646.
8. Hagen NA, Babul N. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer. 1997;79:1428-1437.
9. Gordon DB, Stevenson KK, Griffie J, et al. Opioid equianalgesic calculations. J Palliat Med. 1999;2:209-218.
10. Anderson R, Saiers JH, Abram S, et al. Accuracy in equianalgesic dosing: conversion dilemmas. J Pain Symptom Manage. 2001;21: 397-406.
11. Foley KM. Changing concepts to tolerance to opioids. In: Chapman CR, Foley KM, eds. Current and Emerging Issues in Cancer Pain: Research and Practice (The BMS Symposium on Pain Research). New York, NY: Raven Press: 1993:331-350.
12. Jacox A, Carr DB, Payne R, et al. Management of Cancer Pain. Clinical Practice Guidelines No.9. AHCPR Publication No 940-592. Rockville, MD. Agency for Health Care Policy and Research. U.S. Department of Health and Human Services, Public Health Service; March 1994.
13. Loeser JD. Medical evaluation of the patient with pain. In: Loeser JD, Butler SH, Chapman CR, et al, eds. Bonica's Management of Pain. 3rd ed. New York: Lippincott Williams & Wilkins; 2001: 267-278.
14. Foley KM. Pain assessment and cancer pain syndromes. In: Doyle D, Hanks GW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2nd ed. New York: Oxford University Press; 1998.
15. Tycross RG. Pain and analgesics. Curr Med Res Opin. 1978:5:497.
16. Dunbar PJ, Chapman CR, Buckley FP. et al. Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA. Pain. 1996;68:265-270.
17. Lawlor P, Turner K, Hanson H. et al. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain. 1997;72:79-85.
18. Glare RA, Walsh TD. Dose ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol. 1993;11:973-978.
19. Ginsberg B, Sinatra R, Crews J. et al. Conversion from IV PCA Morphine to Oral Controlled-Release Oxycodone Tablets for Postoperative Pain Management. Paper presented at the 72nd Clinical and Scientific Congress, International Anesthesia Research Society, Orlando, FL March 7-11, 1998.
20. Donner B, Zenz M, Tryba M. et al. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain. 1996;64:527-534.
21. Gutstein HB, Akul H. Opioid Analgesics. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's: The Pharmacologic Basis of Therapeutics. New York: McGraw Hill; 2001:569-619.
22. Drug Facts and Comparisons. St. Louis. Facts and Comparisons; 2000.
23. Foley KM. Houde RW. Methadone in cancer pain management: individualize dose and titrate to effect. J Clin Oncol. 1998;16: 3213-3215.
24. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current review of their possible interactions. Pain. 1995;62:259-274.
25. Inturrisi CE. Opioid pharmacology: tolerance, receptor modulation, and new analgesics In: Payne R, Patt RB, Hill CS, eds. Assessment and Treatment of Cancer Pain. Seattle: IASP Press; 1998:vol. 12.
26. Fitzgibbon DR. Cancer pain: management. In. Loeser JD, Butler SH, Chapman CR, et al, eds. Bonica's Management of Pain. 3rd ed. New York: Lippincott Williams & Wilkins; 2001:659-703.
27. Curtis GB, Johnson GH, Clark P, et al. Relative potency of controlled-release oxycodone and morphine in postoperative pain model. Eur J Clin Pharmacol. 1999;55:425-429.
28. Khojainova N, Santiago-Palma J, Kornick C, et al. Pitfalls of opioid rotation: substituting another opioid for methadone. J of Pain. 2001;2(suppl. 1):35.